2566. Effect of CYP2C19 on Voriconazole Pharmacokinetics in Children with Malignancy or Inborn Errors in Immunity

BACKGROUND: Voriconazole pharmacokinetics (PK) are known to be affected by genetic polymorphisms of drug-metabolizing enzymes such as CYP2C19; however, such information is limited for the pediatric population. METHODS: This was a single-center population PK study. Information regarding patient backg...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Kensuke, Hikino, Keiko, Saito, Jumpei, Matsui, Toshihiro, Utano, Tomoyuki, Takebayashi, Akira, Tomizawa, Daisuke, Kato, Motohiro, Matsumoto, Kimikazu, Ishikawa, Takashi, Kawai, Toshinao, Nakamura, Hidefumi, Miyairi, Isao, Terao, Chikashi, Mushiroda, Taisei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677247/
http://dx.doi.org/10.1093/ofid/ofad500.2183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677247/
http://dx.doi.org/10.1093/ofid/ofad500.2183

Ejemplares similares